Australia markets open in 2 hours 51 minutes

AFT Pharmaceuticals Limited (AFT.NZ)

NZSE - NZSE Delayed price. Currency in NZD
Add to watchlist
3.1000-0.1000 (-3.13%)
At close: 03:08PM NZST
Currency in NZD

Valuation measures4

Market cap (intra-day) 341.29M
Enterprise value 377.45M
Trailing P/E 31.41
Forward P/E 17.21
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.83
Price/book (mrq)8.30
Enterprise value/revenue 3.15
Enterprise value/EBITDA 24.09

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 3-31.87%
S&P500 52-week change 3-5.66%
52-week high 35.0000
52-week low 33.1000
50-day moving average 33.5422
200-day moving average 34.1055

Share statistics

Avg vol (3-month) 320.4k
Avg vol (10-day) 318k
Shares outstanding 5104.69M
Implied shares outstanding 6N/A
Float 828.29M
% held by insiders 173.30%
% held by institutions 15.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2021
Most-recent quarter (mrq)30 Sept 2021


Profit margin 9.04%
Operating margin (ttm)11.50%

Management effectiveness

Return on assets (ttm)8.62%
Return on equity (ttm)30.52%

Income statement

Revenue (ttm)119.8M
Revenue per share (ttm)1.24
Quarterly revenue growth (yoy)13.70%
Gross profit (ttm)48.74M
Net income avi to common (ttm)10.64M
Diluted EPS (ttm)0.1070
Quarterly earnings growth (yoy)256.00%

Balance sheet

Total cash (mrq)5.91M
Total cash per share (mrq)0.06
Total debt (mrq)42.07M
Total debt/equity (mrq)102.36
Current ratio (mrq)2.60
Book value per share (mrq)0.39

Cash flow statement

Operating cash flow (ttm)10.32M
Levered free cash flow (ttm)-2.16M